how glp-1 drugs cause gastroparesis lawsuits Adverse effects of class drugs. Gastrointestinal issues are Ozempic Lawsuit: Are You Owed
Description
infusion of GLP-1 decreased water consumption by 36% in response to i.v
It has been hypothesized that SGLT2-I may alter the absorption and excretion of calcium and phosphate, resulting in reductions in bone health
Retrieved from Aparicio E, Jard C, Bedmar C, et al
Hathaway et al
It is generally accepted that TLR4 plays an essential role in cardiac inflammation, and NF-B serves as a downstream mediator of TLR4 in the heart
My question: given my MS stability but significant metabolic risk factors (obesity, pre-diabetes, cholesterol, thyroid), do you think a GLP-1 agonist (such as tirzepatide or semaglutide) would be a reasonable option for me
